Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection |
Kim, Sun Chul
(Division of Nephrology, Department of Internal Medicine, Korea University Anam Hospital)
Seo, Min Young (Division of Nephrology, Department of Internal Medicine, Korea University Anam Hospital) Lee, Jun Yong (Division of Nephrology, Department of Internal Medicine, Korea University Anam Hospital) Kim, Ki Tae (Division of Nephrology, Department of Internal Medicine, Korea University Anam Hospital) Cho, Eunjung (Division of Nephrology, Department of Internal Medicine, Korea University Anam Hospital) Kim, Myung-Gyu (Division of Nephrology, Department of Internal Medicine, Korea University Anam Hospital) Jo, Sang-Kyung (Division of Nephrology, Department of Internal Medicine, Korea University Anam Hospital) Cho, Won-Yong (Division of Nephrology, Department of Internal Medicine, Korea University Anam Hospital) Kim, Hyoung-Kyu (Division of Nephrology, Department of Internal Medicine, Korea University Anam Hospital) |
1 | Howell MD, Novack V, Grgurich P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010;170:784-790. DOI |
2 | Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect 1998;40:1-15. |
3 | Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 1993;17:109-113. DOI |
4 | McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990;162:678-684. DOI |
5 | McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-210. DOI |
6 | Peniche AG, Savidge TC, Dann SM. Recent insights into Clostridium difficile pathogenesis. Curr Opin Infect Dis 2013;26:447-453. |
7 | Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-2449. DOI |
8 | Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005;173:1037-1042. DOI |
9 | Kuijper EJ, van Dissel JT, Wilcox MH. Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis 2007;20:376-383. |
10 | Eddi R, Malik MN, Shakov R, Baddoura WJ, Chandran C, Debari VA. Chronic kidney disease as a risk factor for Clostridium difficile infection. Nephrology (Carlton) 2010;15:471-475. DOI |
11 | Pardi DS. Recurrent Clostridium difficile infection: an immunodeficiency state? Clin Gastroenterol Hepatol 2007;5:672-673. DOI |
12 | Aronsson B, Barany P, Nord CE, Nystrom B, Stenvinkel P. Clostridium difficile-associated diarrhoea in uremic patients. Eur J Clin Microbiol 1987;6:352-356. DOI |
13 | McConnell JB, Stewart WK, Thjodleifsson B, Wormsley KG. Gastric function in chronic renal failure: effects of maintenance haemodialysis. Lancet 1975;2:1121-1123. |
14 | Hida M, Aiba Y, Sawamura S, Suzuki N, Satoh T, Koga Y. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 1996;74:349-355. DOI |
15 | Keddis MT, Khanna S, Noheria A, Baddour LM, Pardi DS, Qian Q. Clostridium difficile infection in patients with chronic kidney disease. Mayo Clin Proc 2012;87:1046-1053. DOI |
16 | Yousuf K, Saklayen MG, Markert RJ, Barde CJ, Gopalswamy N. Clostridium difficile-associated diarrhea and chronic renal insufficiency. South Med J 2002;95:681-683. |
17 | Mullane KM, Cornely OA, Crook DW, et al. Renal impairment and clinical outcomes of Clostridium difficile in-fection in two randomized trials. Am J Nephrol 2013;38:1-11. DOI |
18 | Monaghan T, Boswell T, Mahida YR. Recent advances in Clostridium difficile-associated disease. Gut 2008;57:850-860. |
19 | Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int 2013;83:1010-1016. DOI |
20 | Betjes MG. Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol 2013;9:255-265. DOI |
21 | Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-455. DOI |